Health Law & Business News

White House Says Other Countries Don’t Pay Enough for Drugs (2)

Feb. 14, 2020, 3:01 PM

The Trump administration criticized foreign governments’ efforts to reduce drug prices in a new report, even as the president and Congress consider measures of their own to control the cost of medicines in the U.S.

The report published Thursday by the White House Council of Economic Advisers argues that coordinated drug-purchasing efforts in other countries, often by government-run programs, result in lower drug costs compared to the U.S. The report describes the practice as “free-riding.”

The CEA report strongly echoes arguments of the pharmaceutical industry. It claims that lower drug spending globally erodes the resources available for researchers to develop...

To read the full article log in. To learn more about a subscription click here.